The use of 10058-F4, a specific inhibitor of MYC-MYC associated factor X (MAX) heterodimerization, effectively restored the impaired function of CD226-deficient Tregs in IBD model [114]. This evidence concerns the gene MYC and inflammatory bowel disease.